If your hairline has quietly moved north over the last few years, or your crown looks thinner in photos than it feels in the mirror, there is a good chance a single hormone is behind it. That hormone is dihydrotestosterone, better known as DHT.
DHT is not a villain. It is a normal, necessary androgen that shapes male development. But in men who are genetically sensitive to it, DHT gradually shrinks hair follicles on the scalp while leaving the rest of the body untouched. Understanding how that process works, and where you actually have leverage, is the difference between guessing and having a plan.
What DHT Is and Where It Comes From
DHT is made from testosterone. An enzyme called 5-alpha-reductase converts a portion of your circulating testosterone into DHT, which then binds to androgen receptors roughly two to three times more strongly than testosterone itself (Kaufman, 2002). There are two main forms of the enzyme. Type 1 is concentrated in sebaceous glands and skin. Type 2 is heavily represented in hair follicles and the prostate.
During puberty, DHT drives facial hair, body hair, and voice change. After that, its most noticeable adult effects are less welcome for a lot of men: scalp hair loss and prostate enlargement.
Why DHT Thins Some Hair and Not Others
Here is the part that confuses people. DHT grows a beard and thins a scalp at the same time, in the same body, from the same hormone. The explanation is receptor sensitivity, not hormone level.
Follicles on the crown, temples, and hairline of genetically susceptible men carry more androgen receptors and more 5-alpha-reductase activity than follicles at the back and sides of the head. When DHT binds to those receptors, it shortens the anagen phase, the active growing stage of the hair cycle, and triggers a process called miniaturization (Randall, 2008). Each new cycle produces a hair that is finer, shorter, and lighter in color than the one before it. Eventually the follicle produces only a wispy vellus hair, and then nothing at all.
This is why men with completely normal blood testosterone can still lose hair, and why men with high testosterone are not automatically doomed. Research comparing men with and without androgenetic alopecia has generally found that scalp tissue sensitivity and local DHT activity matter more than serum hormone readings (Urysiak-Czubatka et al., 2014).
The Hormone Balance Piece
DHT does not operate in isolation. A few other factors influence how aggressively it affects your hair.
Testosterone supply. DHT is downstream of testosterone. Aggressively suppressing testosterone to protect your hairline is a poor trade, since testosterone supports muscle, mood, libido, bone density, and energy. The goal is moderation of conversion, not shutdown of production.
Estrogen and aromatase. Testosterone also converts to estradiol through the aromatase enzyme. When that balance drifts, men can experience changes in body composition, recovery, and mood that compound the frustration of thinning hair.
Cortisol. Chronic stress raises cortisol, which can push follicles prematurely into the resting phase and increase shedding independently of DHT (Thom, 2016). If you are training hard, sleeping poorly, and under work pressure, you may be fighting on two fronts.
Oxidative stress and scalp environment. Follicles are metabolically demanding structures. Inflammation, poor microcirculation, and oxidative damage all reduce the quality of what your follicles can produce (Trueb, 2009).
Nutrient status. Deficiencies in iron, zinc, vitamin D, and protein are well documented contributors to hair shedding, and they are common enough to be worth ruling out before assuming DHT is the whole story (Almohanna et al., 2019; Rushton, 2002).
What Actually Works for DHT Control
Prescription 5-alpha-reductase inhibitors. Finasteride and dutasteride reduce DHT substantially and have strong clinical evidence behind them. They also carry documented side effect profiles, including sexual and mood related effects in a minority of users, which is why some men look for alternatives (Hirshburg et al., 2016). This is a conversation for your doctor, not the internet.
Botanical 5-alpha-reductase inhibitors. Saw palmetto (Serenoa repens) has been studied for both prostate and hair applications. A randomized, double blind, placebo controlled trial of a botanical formula containing saw palmetto reported improvement in a majority of treated men compared with placebo (Prager et al., 2002), and a comparative study found saw palmetto produced measurable improvement in androgenetic alopecia, though less than finasteride (Rossi et al., 2012).
Pumpkin seed extract. A 24 week randomized, double blind, placebo controlled trial in men with androgenetic alopecia found significantly greater hair count increases in the pumpkin seed oil group compared with placebo (Cho et al., 2014).
Green tea catechins. EGCG has been shown in laboratory models to promote hair follicle growth and reduce follicle cell death, suggesting a supporting role at the scalp level (Kwon et al., 2007).
Structural support nutrients. Biotin, keratin, collagen peptides, MSM, and vitamin E do not block DHT. What they do is supply the raw material and the scalp environment your follicles need to build a strong strand once the hormonal pressure is reduced. Blocking without building is only half a strategy.
Lifestyle levers. Sleep, stress management, resistance training, adequate protein, and not smoking all influence the hormonal and circulatory backdrop your follicles operate in. These are unglamorous and genuinely effective.
Setting Realistic Expectations
Three things are worth saying plainly.
First, timing matters enormously. A miniaturized follicle can often be revived. A follicle that has been dormant for a decade generally cannot. The earlier you act, the more you have to work with.
Second, hair moves slowly. The growth cycle runs in months, not weeks. Most clinical trials in this space run 16 to 24 weeks minimum before measuring outcomes, and that is a fair benchmark for your own expectations.
Third, consistency beats intensity. A moderate approach you follow daily for a year will outperform an aggressive protocol you abandon in six weeks.
The Bottom Line
DHT control is not about eliminating an androgen. It is about moderating how much testosterone converts to DHT at the follicle, protecting the follicles you still have, and giving them the structural nutrients and scalp conditions to produce strong hair. Do that consistently, address the stress and nutrition variables alongside it, and you give yourself the best realistic shot at keeping what you have and improving what is thinning.
Talk to a healthcare provider before starting any new supplement, especially if you take medication or have a prostate condition.
PrimeGENIX® DHT Balance
PrimeGENIX® DHT Balance was built around the idea in this article, that effective hair support has to do two jobs at once. It has to moderate the enzymatic conversion of testosterone into DHT at the follicle, and it has to supply the structural materials your hair is actually made of. Formulas that only do the first leave your follicles protected but underfed. Formulas that only do the second are pouring nutrients into follicles that are still under hormonal pressure.
The formula pairs saw palmetto extract and pumpkin seed extract, the two botanicals with the most direct human research behind them for androgenetic hair thinning, with a multi collagen complex drawn from bovine, chicken, marine, and eggshell membrane sources. Keratin, MSM, hyaluronic acid, biotin, and vitamin E round out the structural and scalp support side, and black pepper extract is included to improve absorption of the rest.
Just as important is what DHT Balance is designed not to do. It is formulated for men who train, and the intent is to support hormonal equilibrium without suppressing testosterone, so you are not trading strength, drive, and recovery for your hairline. The suggested serving is three capsules daily taken between meals. PrimeGENIX® products are made in cGMP certified facilities in the United States, verified by third party laboratories, and backed by a 67 day money back guarantee, so you have a full hair cycle to judge results for yourself.
References
-
Kaufman KD. Androgens and alopecia. Molecular and Cellular Endocrinology. 2002;198(1-2):89-95.
-
Randall VA. Androgens and hair growth. Dermatologic Therapy. 2008;21(5):314-328.
-
Urysiak-Czubatka I, Kmiec ML, Broniarczyk-Dyla G. Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia. Advances in Dermatology and Allergology. 2014;31(4):207-215.
-
Cho YH, Lee SY, Jeong DW, et al. Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: a randomized, double blind, placebo controlled trial. Evidence-Based Complementary and Alternative Medicine. 2014;2014:549721.
-
Prager N, Bickett K, French N, Marcovici G. A randomized, double blind, placebo controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. Journal of Alternative and Complementary Medicine. 2002;8(2):143-152.
-
Rossi A, Mari E, Scarno M, et al. Comparative effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia. International Journal of Immunopathology and Pharmacology. 2012;25(4):1167-1173.
-
Kwon OS, Han JH, Yoo HG, et al. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Phytomedicine. 2007;14(7-8):551-555.
-
Hirshburg JM, Kelsey PA, Therrien CA, et al. Adverse effects and safety of 5-alpha reductase inhibitors: a systematic review. Journal of Clinical and Aesthetic Dermatology. 2016;9(7):56-62.
-
Thom E. Stress and the hair growth cycle: cortisol induced hair growth disruption. Journal of Drugs in Dermatology. 2016;15(8):1001-1004.
-
Trueb RM. Oxidative stress in ageing of hair. International Journal of Trichology. 2009;1(1):6-14.
-
Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The role of vitamins and minerals in hair loss: a review. Dermatology and Therapy. 2019;9(1):51-70.
-
Rushton DH. Nutritional factors and hair loss. Clinical and Experimental Dermatology. 2002;27(5):396-404.